Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667762 | SCV000792264 | uncertain significance | Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins | 2017-06-20 | criteria provided, single submitter | clinical testing | |
EGL Genetic Diagnostics, |
RCV000734954 | SCV000863135 | uncertain significance | not provided | 2018-08-22 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV000667762 | SCV001150302 | pathogenic | Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins | 2018-01-16 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000734954 | SCV001231171 | likely pathogenic | not provided | 2019-10-24 | criteria provided, single submitter | clinical testing | This variant, c.1073_1081dup, results in the insertion of 3 amino acids to the TRMU protein (p.Gln358_Val360dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs753112330, ExAC 0.01%). This variant has been observed in individuals with acute infantile liver failure (PMID:21169334, 30369941). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 552491). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |